Abstract
Functional dyspepsia and the irritable bowel syndrome cause gastrointestinal symptoms in up to 15% of adults in most parts of the world. The term functional dyspepsia largely describes epigastric fullness, early satiety, epigastric pain or epigastric “burning”, while the term irritable bowel syndrome describes abdominal pain associated with changes in the frequency of defecation and the appearance of stools. The pathogenesis of symptoms appears to vary in different individuals but includes psychosocial distress, psychiatric disorders, genetic factors, visceral hypersensitivity, activation of mucosal immunity, altered gastrointestinal motility, dietary factors and changes in the intestinal microbiome and intestinal permeability. Although investigations to exclude non-functional disorders will be needed in many patients, the challenge is to emerge with a positive diagnosis of a functional disorder without extensive or repeated endoscopic or radiological procedures. Management is facilitated by an effective doctor-patient relationship and may include psychological assessment and counselling, stress-reduction techniques, exercise programmes and dietary advice such as the low-FODMAP diet. Medication will be needed in some patients but needs to be individualized because of wide variation in gastrointestinal symptoms and the presence or absence of significant psychiatric disorders.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Recommended Reading
Chang L, Di Lorenzo C, Farrugia G, et al. Functional bowel disorders: a roadmap to guide the next generation of research. Gastroenterology. 2018;154:723–35.
Drossman DA, Hasler WL. Rome 1 V Functional GI disorders: disorders of gut-brain interaction. Gastroenterology. 2016;150:1257–61.
Ford AC, Lacy BE, Talley NJ. Irritable bowel syndrome. N Engl J Med. 2017;376:2566–78.
Gwee K-A, Ghoshal UC, Chen M. Irritable bowel syndrome in Asia: pathogenesis, natural history, epidemiology and management. J Gastroenterol Hepatol. 2018;33:99–110.
Moayyedi PM, Lacy BE, Andrews CN, Enns RA, Howden CW, Vakil N. ACG and CAG clinical guidelines: management of dyspepsia. Am J Gastroenterol. 2017;112:988–1013.
Sahoo S, Padhy SK. Cross-cultural and psychological issues in irritable bowel syndrome. J Gastroenterol Hepatol. 2017;32:1679–85.
Tack J, Talley NJ. Functional dyspepsia-symptoms, definitions and validity of the Rome 111 criteria. Nat Rev Gastroenterol Hepatol. 2013;10:134–41.
Talley NJ, Silverstein MD, Agreus L, Sonnenberg A, Holtmann G. AGA Technical review: evaluation of dyspepsia. Gastroenterology. 1998;114:582–95.
Vanheel H, Carbone F, Valvekens L, et al. Pathophysiological abnormalities in functional dyspepsia subgroups according to the Rome 111 criteria. Am J Gastroenterol. 2017;112:132–40.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Roberts-Thomson, I.C. (2019). Functional Dyspepsia and the Irritable Bowel Syndrome. In: Wichmann, M., McCullough, T., Roberts-Thomson, I., Maddern, G. (eds) Gastroenterology For General Surgeons. Springer, Cham. https://doi.org/10.1007/978-3-319-92768-8_1
Download citation
DOI: https://doi.org/10.1007/978-3-319-92768-8_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-92767-1
Online ISBN: 978-3-319-92768-8
eBook Packages: MedicineMedicine (R0)